These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1396894)

  • 1. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Robertson B; Curstedt T; Tubman R; Strayer D; Berggren P; Kok J; Koppe J; van Sonderen L; Halliday H; McClure G
    Eur J Pediatr; 1992 May; 151(5):372-6. PubMed ID: 1396894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group.
    Bevilacqua G; Halliday H; Parmigiani S; Robertson B
    J Perinat Med; 1993; 21(5):329-40. PubMed ID: 8126628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Eur J Pediatr; 1991 Apr; 150(6):433-9. PubMed ID: 2040354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of curosurf for severe respiratory distress syndrome: a case-control study.
    Valls-i-Soler A; Lizarraga M; López de Heredia J; Roman L; Hernáez E; Gastiasoro E
    Biol Neonate; 1992; 61 Suppl 1():21-5. PubMed ID: 1391261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
    Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of surfactant administration in neonates with respiratory distress syndrome. III. The role of intra-uterine stimulation on lung maturity].
    Gadzinowski J; Halliday H; Szymankiewicz M; Breborowicz G; Sackey S; Sobczak E
    Ginekol Pol; 1993 Feb; 64(2):74-7. PubMed ID: 8359730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: implications for nursing care.
    Sittlington N; Tubman R; Halliday HL
    Midwifery; 1991 Mar; 7(1):20-4. PubMed ID: 2011088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
    Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
    Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique story in neonatal research: the development of a porcine surfactant.
    Curstedt T; Halliday HL; Speer CP
    Neonatology; 2015; 107(4):321-9. PubMed ID: 26044099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial.
    Tubman TR; Halliday HL; Normand C
    BMJ; 1990 Oct; 301(6756):842-5. PubMed ID: 2126475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of porcine surfactant replacement (Curosurf) for severe neonatal respiratory distress syndrome.
    Tubman TR; Halliday HL; Normand C
    J Perinat Med; 1991; 19 Suppl 1():403-7. PubMed ID: 1779394
    [No Abstract]   [Full Text] [Related]  

  • 15. Follow-up on infants treated with porcine surfactant replacement for severe neonatal and infant respiratory distress syndrome: antigenic reactivity evaluation.
    Marraro G; Foresti B; Casiraghi G; Monici Preti P
    Drugs Exp Clin Res; 1991; 17(10-11):511-5. PubMed ID: 1841041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of treating neonates with surfactants for respiratory distress syndrome. I. Importance of gas exchange].
    Gadzinowski J; Szymankiewicz M; Twarowska I; Halliday H
    Ginekol Pol; 1992; 63(3):101-4. PubMed ID: 1303908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.
    Rebello CM; Precioso AR; Mascaretti RS;
    Einstein (Sao Paulo); 2014; 12(4):397-404. PubMed ID: 25628188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response after surfactant treatment of newborn infants with respiratory distress syndrome.
    Bambang Oetomo S; Bos AF; de Lei L; Okken A; van Sonderen L; Halliday HL; Walti H
    Biol Neonate; 1993; 64(6):341-5. PubMed ID: 8286559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant replacement therapy and the prevalence of acute retinopathy of prematurity.
    Tubman TR; Rankin SJ; Halliday HL; Johnston SS
    Biol Neonate; 1992; 61 Suppl 1():54-8. PubMed ID: 1391267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.